Imperial Valley News
Washington, DC - Global pharmaceutical company Novartis AG has agreed to divest all assets related to its BRAF and MEK inhibitor drugs, currently in development, to Boulder, Colorado-based Array BioPharma to settle charges that Novartis’s $16 billion acquisition of GlaxoSmithKline’s portfolio of cancer-treatment drugs would likely be anticompetitive.
Los Angeles, California - Paving the way for lighter and more flexible solar devices, UCLA researchers have identified the key principles for developing high-efficiency polymer solar cells.
Los Angeles, California - The James Irvine Foundation has awarded a $200,000 grant to support the USC Latino Alumni Association Scholarship and Leadership Development Program. The one-year grant will be used to provide scholarships and support to Latino students and others at USC who demonstrate a commitment to the Latino community and participate in leadership-training activities.
Los Angeles, California - Using a newly developed X-ray source, scientists have revealed how a new type of pain-relievers works – bonding to the same neuroreceptors that morphine does, but without the accompanying physical dependence.
Davis, California - Switching from diesel fuel to natural gas may hold advantages for the nation’s heavy-duty trucking fleet, but more needs to be done to reach the full environmental benefits, according to a report released today from the Institute of Transportation Studies at the University of California, Davis, and Rice University.
Davis, California - Heavily marketed as a safer, healthful alternative to smoking, electronic cigarettes are under fire from California health officials who have declared “vaping” a public health threat, hoping to head off the type of deceptive manipulation that tobacco companies succeeded with for decades, according to new research from the University of California, Davis.